Cardiac imaging in patients with chronic liver disease

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Cardiac imaging in patients with chronic liver disease. / Wiese, Signe; Hove, Jens D; Møller, Søren.

I: Clinical Physiology and Functional Imaging, Bind 37, Nr. 4, 07.2017, s. 347-356.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Wiese, S, Hove, JD & Møller, S 2017, 'Cardiac imaging in patients with chronic liver disease', Clinical Physiology and Functional Imaging, bind 37, nr. 4, s. 347-356. https://doi.org/10.1111/cpf.12311

APA

Wiese, S., Hove, J. D., & Møller, S. (2017). Cardiac imaging in patients with chronic liver disease. Clinical Physiology and Functional Imaging, 37(4), 347-356. https://doi.org/10.1111/cpf.12311

Vancouver

Wiese S, Hove JD, Møller S. Cardiac imaging in patients with chronic liver disease. Clinical Physiology and Functional Imaging. 2017 jul.;37(4):347-356. https://doi.org/10.1111/cpf.12311

Author

Wiese, Signe ; Hove, Jens D ; Møller, Søren. / Cardiac imaging in patients with chronic liver disease. I: Clinical Physiology and Functional Imaging. 2017 ; Bind 37, Nr. 4. s. 347-356.

Bibtex

@article{34a4e26629e0491881a789909dcdfc5e,
title = "Cardiac imaging in patients with chronic liver disease",
abstract = "Cirrhotic cardiomyopathy (CCM) is characterized by an impaired contractile response to stress, diastolic dysfunction and the presence of electrophysiological abnormalities, and it may be diagnosed at rest in some patients or demasked by physiological or pharmacological stress. CCM seems to be involved in the development of hepatic nephropathy and is associated with an impaired survival. In the field of cardiac imaging, CCM is not yet a well-characterized entity, hence various modalities of cardiac imaging have been applied. Stress testing with either physiologically or pharmacologically induced circulatory stress has been used to assess systolic dysfunction. Whereas echocardiography with tissue Doppler is by far the most preferred method to detect diastolic dysfunction with measurement of E/A- and E/E'-ratio. In addition, echocardiography may also possess the potential to evaluate systolic dysfunction at rest by application of new myocardial strain techniques. Experience with other modalities such as cardiac magnetic resonance imaging and cardiac computed tomography is limited. Future studies exploring these imaging modalities are necessary to characterize and monitor the cardiac changes in cirrhotic patients.",
author = "Signe Wiese and Hove, {Jens D} and S{\o}ren M{\o}ller",
note = "{\textcopyright} 2015 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.",
year = "2017",
month = jul,
doi = "10.1111/cpf.12311",
language = "English",
volume = "37",
pages = "347--356",
journal = "Clinical Physiology and Functional Imaging",
issn = "1475-0961",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Cardiac imaging in patients with chronic liver disease

AU - Wiese, Signe

AU - Hove, Jens D

AU - Møller, Søren

N1 - © 2015 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

PY - 2017/7

Y1 - 2017/7

N2 - Cirrhotic cardiomyopathy (CCM) is characterized by an impaired contractile response to stress, diastolic dysfunction and the presence of electrophysiological abnormalities, and it may be diagnosed at rest in some patients or demasked by physiological or pharmacological stress. CCM seems to be involved in the development of hepatic nephropathy and is associated with an impaired survival. In the field of cardiac imaging, CCM is not yet a well-characterized entity, hence various modalities of cardiac imaging have been applied. Stress testing with either physiologically or pharmacologically induced circulatory stress has been used to assess systolic dysfunction. Whereas echocardiography with tissue Doppler is by far the most preferred method to detect diastolic dysfunction with measurement of E/A- and E/E'-ratio. In addition, echocardiography may also possess the potential to evaluate systolic dysfunction at rest by application of new myocardial strain techniques. Experience with other modalities such as cardiac magnetic resonance imaging and cardiac computed tomography is limited. Future studies exploring these imaging modalities are necessary to characterize and monitor the cardiac changes in cirrhotic patients.

AB - Cirrhotic cardiomyopathy (CCM) is characterized by an impaired contractile response to stress, diastolic dysfunction and the presence of electrophysiological abnormalities, and it may be diagnosed at rest in some patients or demasked by physiological or pharmacological stress. CCM seems to be involved in the development of hepatic nephropathy and is associated with an impaired survival. In the field of cardiac imaging, CCM is not yet a well-characterized entity, hence various modalities of cardiac imaging have been applied. Stress testing with either physiologically or pharmacologically induced circulatory stress has been used to assess systolic dysfunction. Whereas echocardiography with tissue Doppler is by far the most preferred method to detect diastolic dysfunction with measurement of E/A- and E/E'-ratio. In addition, echocardiography may also possess the potential to evaluate systolic dysfunction at rest by application of new myocardial strain techniques. Experience with other modalities such as cardiac magnetic resonance imaging and cardiac computed tomography is limited. Future studies exploring these imaging modalities are necessary to characterize and monitor the cardiac changes in cirrhotic patients.

U2 - 10.1111/cpf.12311

DO - 10.1111/cpf.12311

M3 - Review

C2 - 26541640

VL - 37

SP - 347

EP - 356

JO - Clinical Physiology and Functional Imaging

JF - Clinical Physiology and Functional Imaging

SN - 1475-0961

IS - 4

ER -

ID: 161388068